Wegovy CVOT Data Could Pave The Way For Broad Reimbursement, CEO Says

 
• By Jessica Merrill
  
heart versus money
positive CV data could make Wegovy a better value to payers • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category